Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Transcriptome-Wide Association Study Identifies New Candidate Susceptibility Genes for Glioma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. A large-cohort, longitudinal study determines pre-cancer disease routes across different cancer types

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Genetic data from nearly 63,000 women of European descent predicts DNA methylation biomarkers and epithelial ovarian cancer risk

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Ovarian removal at or after benign hysterectomy and breast cancer: a nationwide cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Use of nonaspirin nonsteroidal anti-inflammatory drugs and risk of head and neck cancer: A nationwide case-control study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Prevalence, type distribution, and risk factors for oral HPV in Danish renal transplant recipients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Human papillomavirus vaccination in immigrants and descendants of immigrants in Denmark

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Bridget Charbonneau
  • Matthew S Block
  • William R Bamlet
  • Robert A Vierkant
  • Kimberly R Kalli
  • Zachary Fogarty
  • David N Rider
  • Thomas A Sellers
  • Shelley S Tworoger
  • Elizabeth Poole
  • Harvey A Risch
  • Helga B Salvesen
  • Lambertus A Kiemeney
  • Laura Baglietto
  • Graham G Giles
  • Gianluca Severi
  • Britton Trabert
  • Nicolas Wentzensen
  • Georgia Chenevix-Trench
  • Alice S Whittemore
  • Weiva Sieh
  • Jenny Chang-Claude
  • Elisa V Bandera
  • Irene Orlow
  • Kathryn Terry
  • Marc T Goodman
  • Pamela J Thompson
  • Linda S Cook
  • Mary Anne Rossing
  • Roberta B Ness
  • Steven A Narod
  • Jolanta Kupryjanczyk
  • Karen Lu
  • Ralf Butzow
  • Thilo Dörk
  • Tanja Pejovic
  • Ian Campbell
  • Nhu D Le
  • Clareann H Bunker
  • Natalia Bogdanova
  • Ingo B Runnebaum
  • Diana Eccles
  • James Paul
  • Anna H Wu
  • Simon A Gayther
  • Estrid Hogdall
  • Florian Heitz
  • Claus K Hogdall
  • Susanne Kruger Kjaer
  • Lene Lundvall
  • for AOCS/ACS group
Vis graf over relationer

A missense single-nucleotide polymorphism (SNP) in the immune modulatory gene IL1A has been associated with ovarian cancer risk (rs17561). Although the exact mechanism through which this SNP alters risk of ovarian cancer is not clearly understood, rs17561 has also been associated with risk of endometriosis, an epidemiologic risk factor for ovarian cancer. Interleukin-1α (IL1A) is both regulated by and able to activate NF-κB, a transcription factor family that induces transcription of many proinflammatory genes and may be an important mediator in carcinogenesis. We therefore tagged SNPs in more than 200 genes in the NF-κB pathway for a total of 2,282 SNPs (including rs17561) for genotype analysis of 15,604 cases of ovarian cancer in patients of European descent, including 6,179 of high-grade serous (HGS), 2,100 endometrioid, 1,591 mucinous, 1,034 clear cell, and 1,016 low-grade serous, including 23,235 control cases spanning 40 studies in the Ovarian Cancer Association Consortium. In this large population, we confirmed the association between rs17561 and clear cell ovarian cancer [OR, 0.84; 95% confidence interval (CI), 0.76-0.93; P = 0.00075], which remained intact even after excluding participants in the prior study (OR, 0.85; 95% CI, 0.75-0.95; P = 0.006). Considering a multiple-testing-corrected significance threshold of P < 2.5 × 10(-5), only one other variant, the TNFSF10 SNP rs6785617, was associated significantly with a risk of ovarian cancer (low malignant potential tumors OR, 0.85; 95% CI, 0.79-0.91; P = 0.00002). Our results extend the evidence that borderline tumors may have a distinct genetic etiology. Further investigation of how these SNPs might modify ovarian cancer associations with other inflammation-related risk factors is warranted.

OriginalsprogEngelsk
TidsskriftCancer Research
Vol/bind74
Udgave nummer3
Sider (fra-til)852-61
Antal sider10
ISSN0008-5472
DOI
StatusUdgivet - 1 feb. 2014

ID: 44866506